Materialise

PLYMOUTH — Materialise, the Belgian developer of software and services for the 3D printing industry with its North American headquarters in Plymouth, announced that it has received clearance from the U.S. Food and Drug Administration for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement